sbarrett, I couldn't sell them 90%.
This new TAVR, if it jumps through all the hoops, will possibly be the 'Rolls Royce' of TAVR.
If it's that good they'll do quite nicely out of their investment I would imagine.
These top Clinicians assisting with it's development seem to think it's very worthy of been involved in.
Admedus with their 3D tech and the TAVR , if it passes all the appropriate testing, I would like to think will make a huge statement for the company, that surgeons around the the world will recognise Admedus as a company that makes great products that are surgeon friendly, do the job and can be trusted.
Regards
Dabru
Ann: Extension of Voluntary Suspension, page-59
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.91 |
Change
-0.090(0.90%) |
Mkt cap ! $209.4M | |||
| Open | High | Low | Value | Volume |
| $10.00 | $10.00 | $9.65 | $70.76K | 7.202K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $9.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.91 | 475 | 2 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |